## 3 Results and Discussion
### Univariate Data Analysis
#### 3.1.2 Routine Blood Analyses
\begin{table}
\begin{tabular}{p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt} p{113.8 pt}} \hline \multirow{3}{*}{**Variables**} & \multicolumn{5}{c}{**Outcome**} \\ \cline{3-11}  & \multirow{2}{*}{**Nomality Range**} & \multicolumn{1}{p{113.8 pt}}{**A Range**} & \multicolumn{1}{p{113.8 pt}}{**B Discharged, no INV (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**A + B Discharged, INV (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**C C**} & \multicolumn{1}{p{113.8 pt}}{**\(p\)-Value**} & \multicolumn{1}{p{113.8 pt}}{**\(p\)-Value**} & \multicolumn{1}{p{113.8 pt}}{**\(p\)-Value**} \\  & & \multicolumn{1}{p{113.8 pt}}{**Discharged, INV (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**Discharged (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**Dressed (n = 16)**} & \multicolumn{1}{p{113.8 pt}}{**Dressed (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**Dressed (n = 8)**} & \multicolumn{1}{p{113.8 pt}}{**A + B vs. C**} \\ \hline Neutrophil count, \(\times 10^{9}/\)L & 2.0–8.5 & 7.71 (5.99–10.98) & 7.86 (6.00–18.08) & 7.71 (6.00–11.40) & 9.81 (5.77–16.01) & 0.721 (5.77–16.01) & 1.000 (5.677) \\ \hline Eosinophil count, \(\times 10^{9}/\)L & 0.0–0.6 & 0.09 (0.02–0.17) & 0.11 (0.02–0.15) & 0.09 (0.02–0.15) & 0.05 (0.02–0.15) & 1.00 (0.02–0.17) & 1.000 (0.01–0.17) & 1.000 (0.01–0.17) & 1.000 (0.01–0.17) & 0.573 (0.047) \\ \hline Lymphocyte count, \(\times 10^{9}/\)L & 0.9–3.5 & 1.26 (1.13–1.41) & 1.32 (0.74–1.68) & 1.22 (0.94–1.53) & 1.27 (0.54–0.75) & 0.798 (0.015) & **0.003** \\ \hline RBC count, \(\times 10^{12}/\)L & 4.4–5.9 & 4.39 (4.15–4.85) & 3.88 (3.79–4.35) & 4.19 (3.87–4.49) & 3.71 (2.85–3.94) & **0.028** & 0.105 (0.005) \\ \hline Ferritin, ng/mL & 30–340 & 1221.40 (500.0–6552.75) & 1591.10 (1118.0) & 1432.5 (5111.80) & 1776.60 (5194.8–3) & 1776.60 (5195.0–3) & 0.690 (0.690) & 0.571 (0.573) \\  & & 0.2–5 & 3719.30) & 5525.00 (0.0–0.15) & 0.2–5 (0.29–55) & 0.2–5 (0.29–55) & 0.505 (0.50) & 0.798 (0.787) \\ \hline Platelet count, \(\times 10^{9}/\)L & 150–450 & 309.50 (220.75–380.75) & 255.50 (166.25–357.35) & 290.0 (209.75–360.50) & 288.00 (2530.50) & 0.505 (0.798) & 0.787 (0.787) \\  & & & 6.20 (6.20) & 6.10 (8.0–0.1) & 4.60 (5.0–7.33) & (5.0–7.85) & 4.60 (5.0–7.85) & 0.905 (0.90–3) & 0.714 (0.482) \\  & & & 0.8–6 & 0.9–9 & 0.9–9 & 0.9–3 & 0.905 (0.714) & 0.482 (0.82) \\ \hline D-dimers, \(\mu\)g/L & \(<\)230 & 1805.00 (273.00–4043.75) & 2104.50 (623.50) & 2104.50 (623.50) & 2104.50 (3089.50) & 987.00 (3091.00) & 0.755 (0.613) & 0.636 (0.636) \\  & & & 0.8–6 & 3123.50) & 0.30 (0.14 (0.12–15.4) & 0.14 (0.05–0.39) & 0.29 (0.08–3) & 0.132 (0.90–3) & 0.905 (0.536) \\  & & & 0.8–6 & 0.8–6 & 0.8–12 & 0.14 (0.12–15.4) & 0.29 (0.08–3) & 0.132 (0.90–3) & 0.905 (0.536) \\ \hline CRP, mg/L & \(<\)5 & 46.50 (16.25–116.38) & 206.65 (67.03–0.297.3) & 202.65 (220.73) & 214.50 (519.63–0.37) & **0.028** & 1.000 (0.288) & 0.238 (0.00–0.28) \\ \hline LDH, U/L & 125–220 & 518.00 (322.00–615.00) & 388.00 (354.00–0.27) & 392.50 (354.00–0.80) & 392.50 (357.25–38.50) & 0.535 (0.628) & 1.000 (0.00–0.28) \\  & & & 0.8–7 & 478.00: n.s.2 & 812.5 (1.2) & 526.25: n.s.6 & & \\ \hline Creatinine, mg/dL & 0.72–1.25 & 0.73 (0.66–0.84) & 0.75 (0.63–1.00) & 0.74 (0.65–0.85) & 0.96 (0.65–1.42) & 1.000 (0.382) & 0.214 (0.21) \\ \hline hs-cTn l, pg/mL & \(<\)34.2 & 2.15 (1.90–3.35) & 9.95 (3.30–257.98) & 3.40 (1.95–12.73) & 4.30 (7.55–285.30) & **0.026** & 0.429 (**0.037** \\  & & & 0.8–6 & n.s.2 & n.s.5 & & \\ \hline \end{tabular}
\end{table} 
Table 3: Routine blood analyses by patient group, and intergroup comparisons. marker of increased coagulation activity is high D-dimer levels, helping in the diagnosis of thrombosis and disseminated intravascular coagulation. As reported by other researchers, D-dimer levels above 2 mg/L can be used as mortality indicators with 92% sensitivity and 83% of specificity in COVID-19 [52]. In the context of a viral infection, fibrinogen levels also tend to increase, for example due to the secondary effects of the imposed cytokine storm, which contributes to a hypercoagulable state in patients [53].